Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi
Condition: Multicentric Castleman Disease Interventions: Drug: Rituximab; Drug: Etoposide Sponsors: UNC Lineberger Comprehensive Cancer Center; Fogarty International Center of the National Institute of Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Malawi Health | National Institutes of Health (NIH) | Research | Rituxan